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ABSTRACT
Purpose. The purpose of this study was to compare CT-navigated stereotactic IRE
(SIRE) needle placement to non-navigated conventional IRE (CIRE) for percutaneous
ablation of liver malignancies.
Materials andMethods. A prospective trial including a total of 20 patients was
conducted with 10 patients in each arm of the study. IRE procedures were guided using
either CT fluoroscopy (CIRE) or a stereotactic planning and navigation system (SIRE).
Primary endpoint was procedure time. Secondary endpoints were accuracy of needle
placement, technical success rate, complication rate and dose-length product (DLP).
Results. A total of 20 IRE procedures were performed to ablate hepatic malignancies
(16 HCC, 4 liver metastases), 10 procedures in each arm. Mean time for placement
of IRE electrodes in SIRE was significantly shorter with 27 ± 8 min compared to
87 ± 30 min for CIRE (p< 0.001). Accuracy of needle placement for SIRE was higher
than CIRE (2.2 mm vs. 3.3 mm mean deviation, p< 0.001). The total DLP and the
fluoroscopy DLP were significantly lower in SIRE compared to CIRE. Technical success
rate and complication rates were equal in both arms.
Conclusion. SIRE demonstrated a significant reduction of procedure length and
higher accuracy compared to CIRE. Stereotactic navigation has the potential to reduce
radiation dose for the patient and the radiologist without increasing the risk of
complications or impaired technical success compared to CIRE.
Subjects Oncology, Radiology and Medical Imaging, Surgery and Surgical Specialties
Keywords Interventional radiology, Robotic assistance, Irreversible electroporation, Liver tumor,
CT-guided, Stereotactic navigation
INTRODUCTION
Irreversible Electroporation (IRE) is a novel method for focused treatment of liver tumors
(Rubinsky, 2007). IRE is a soft tissue ablation technique using ultra-short but strong
electrical fields to create permanent and hence lethal nanopores in the cell membrane
in order to disrupt cellular homeostasis (Davalos, Mir & Rubinsky, 2005). The cell death
results mainly from apoptosis and not necrosis as in all other thermal or radiation-based
ablation techniques although local coagulation necrosis has been shown in the immediate
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proximity to the electrodes (Ben-David et al., 2013). IRE is used for non-resectable liver
tumors in the vicinity of vessels (due to its selectivity for tumor tissue while preserving
vessel structures as well as the absence of the so-called heat sink effect) (Rubinsky, Onik &
Mikus, 2007). IRE has also recently shown therapeutic efficacy and safety in other organs
like pancreas and prostate (Martin et al., 2015; Ting et al., 2016). First animal studies have
shown the safety and feasibility of stereotactically delivered IRE for the treatment of
telencephalic gliomas (Rossmeisl et al., 2015).
IRE ablation requires the placement of two or more applicator electrodes between which
the electrical fields are applied. In order to achieve successful ablation, parallel needle
placement at a pre-defined distance between 1.5 cm and 2 cm is required. Mathematic
models have shown that parallel placement of IRE electrodes is essential to generate an even
distribution of the electromagnetic field (Edd & Davalos, 2007). This fact was also shown in
porcine animal model by Ben-David et al. (2013) who investigated the therapeutic efficacy
of IRE with regard to electrode orientation, tissue type and local environment.
Needles are placed under image guidance using ultrasound or computer tomography as
imaging methods. Since these methods display one image plane at a time, the realization of
multiple parallel needle placements can be challenging. Several attempts may be necessary
to achieve the required geometrical configuration of the needle with respect to other needles
and as well as in relation to the anatomical target.
Navigation technology for interventional radiology supports IRE treatments by
providing comprehensive planning of needle configurations using 3D image data and
by supporting needle placement through guidance functionality.
This study aims to investigate the potential benefits of CT-navigated stereotactic IRE
(SIRE) needle placement compared to non-navigated conventional IRE (CIRE) for ablation
of malignant liver lesions.
MATERIALS AND METHODS
Study design, participant selection and patient characteristics
In a prospective, non-blinded, non-randomized two-armed study carried out between July
2015 and February 2016, IRE ablations of malignant liver tumors were performed in 10
procedures with stereotactic navigation and 10 cases without. The primary end point of
the study was the time required until start of the ablation (measured from the time of
the first CT scan to the start of the ablation). Secondary endpoints included accuracy of
IRE electrode placement (accuracy is measured as lateral deviation of the IRE electrodes
to a central reference electrode); overall procedure time; number of needle replacements;
radiation dose and number of control scans.
The study has been approved by the Ethics Committee of the University Regensburg
(approval number 15-101-0188) and written consent was obtained from all patients. All
procedures were performed according to the Declaration of Helsinki and the guideline for
Good Clinical Practice from the International Conference on Harmonization.
In all cases, indication for percutaneous tumor ablation was determined by an
interdisciplinary tumor board. An IRE was indicated if surgical resection was not possible,
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Table 1 Number of ablated lesions with and without stereotactic navigation.
Conventional or stereotactic SIRE CIRE
Hepatocellular carcinoma 10 6
Metastasis of colorectal cancer 0 4
All 10 10
i.e., because no R0 resection was possible or an increased risk of insufficient hepatic
functional reserve, and if radiofrequency ablation (RFA) and microwave ablation (MWA)
were contraindicated. Exclusion criteria included any condition which, in the judgment of
the clinical investigator or his designee, might increase the risk to the subject or decrease
the chance of obtaining satisfactory data to achieve the objectives of the study. Patients
with hereditary hematological / coagulation disorders unrelated to their liver disease were
likewise excluded. Patients who were currently (within the last 30 days prior to surgery)
participating in another clinical trial with any investigational drug or device were ruled
out, as well as those patients undergoing liver surgery for the purpose of receiving a liver
transplant.
The registration of the study (ISRCTN55383115) was applied after it was completed,
since the project was initially conducted as an internal evaluation of the navigation device.
In total the study comprised 20 IRE procedures performed on primary liver tumors and
liver metastases in 20 patients (two female, 18 male, average age 66 years, age range
46–81 years). The first 10 procedures were performed using CT fluoroscopy without
navigation assistance (CIRE), the other 10 using stereotactic navigation (SIRE; Fig. 1).
In all cases a pre-interventional MRI examination had been performed using liver-
specific contrast (Primovist, Bayer Schering Pharma, Berlin) as reference imaging. 16 of
the 20 ablated lesions were hepatocellular carcinomas; the other four were colorectal liver
metastases (Table 1).
IRE procedure
All interventions were performed under full anesthesia with deep muscle relaxation by
one experienced interventional radiologist (more than 400 percutaneous tumor ablations
done). After acquisition of an arterial and portal venous planning CT (Somatom Sensation
16; Siemens Healthcare, Forchheim, Germany) with respiration control (endotracheal
tube disconnection), DICOM data were transferred optionally to the navigation system
(CAS-One I; CAScination AG, Bern, Switzerland) or to manual planning on the PACS
system.
In the SIRE group radiopaque optical markers were placed on the patient before
acquisition of the planning CT. The navigation system was placed next to the CT gantry
and the optical tracking camera was set up above the patient in a way, that it could effectively
track both the optical markers placed on the patient and the navigation device.
Programming of the IRE generator (NanoKnife System; AngioDynamics R©, Latham,
NewYork, NY, USA) was performed in both arms of the study following themanufacturer’s
instructions: electric field, 1,500 V/cm needle distance; pulse length, 90 µs; pulses per cycle,
90. Before delivering the 90 therapeutic pulses, a test pulse at 270 V was delivered. After
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Figure 1 Flow of participants through each stage of the study.
the test pulse confirmed adequate conductivity, 90 pulses were delivered in less than
2 min. When the current generated by the electrodes exceeded 48 amps, those electrodes
were withdrawn from the therapeutic algorithm and pulses between those electrodes were
aborted.
Post-interventionally all patients received 20 mg Enoxaparin subcutaneously once a day
until full mobilization.
Non-navigated conventional IRE (CIRE)
CT fluoroscopy (CARE Vision, Somatom Sensation 16; Siemens Healthcare, Forchheim,
Germany; CT parameters during fluoroscopy: tube voltage 120 kVp; effective tube current-
time product 30 mAs; slice collimation 16 mm × 0.75 mm) is an acquisition mode that
allows continuous image update using in-room table control. A final position control scan
was performed after iterative insertion of 2–6 monopolar 18-gauge ablation electrodes by
needle advancement and using image control.
Navigated stereotactic IRE (SIRE)
Prior to acquisition of the planning CT, the patient was immobilized in a vacuum fixation
system (iSYS Medizintechnik GmbH, Kitzbühl, Austria), and optical fiducial markers were
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Figure 2 Planning the path of access on the navigation system. A virtual entry point on the skin and tumor center is defined. Then the trajectories
of the individual electrodes are calculated, but can still be adjusted individually.
attached to the patients’ chests to register image-to-patient coordinates. Based on the
transmitted DICOM data, the navigation system software was used to define the tumor
localization as well as to plan the access path of the IRE electrodes.
For parallel electrode placement, the software allows the selection of different geometric
patterns depending on the number of required electrodes, e.g., rectangular or three-
cornered shapes (Fig. 2). The entry point on the skin and distance between the electrodes
have to be determined by the interventionalist. Each trajectory can be individually adjusted
to avoid critical structures.
Upon the conclusion of planning, the needle guidance device was aligned with the
navigation system to the planned path of access, and the electrode was inserted (Fig. 3).
Once all electrodes were placed, a needle position control scan was performed.
Radiation exposure dose
The total dose-length product (DLP), fluoroscopy DLP and the number of verification
scans to check the location of the needle during the intervention were recorded.
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Figure 3 Positioning the needle guidance device for inserting the IRE electrodes.
Figure 4 Evaluation of the lateral deviation of the IRE electrodes. (A) Orthogonal plane (thickness 0.7
mm) at the tip of the reference electrode. (B) Orthogonal plane at a distance of 3 cm from the tip of the
reference electrode. (C) Fusion of (A) and (B) with determination of lateral probe deviations.
Procedural accuracy
Accuracy of IRE needle placement is measured as the degree of parallelism defined as the
lateral deviation of each IRE electrode over the last 3 cm (from the probe tip) with respect
to a reference electrode defined as the probe in the most central position in the tumor
(Fig. 4).
Complications
Complications were documented and classified as minor and major complications
according to the standardized grading system of the Society of Interventional Radiology
(Omary et al., 2003).
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Figure 5 Colorectal liver metastasis in close relationship to the right portal vein. (A) Late phase MRI
shows complete ablation (B) after stereotactic placement of 3 IRE electrodes above and 2 below the portal
vein (C).
Follow-up
All patients underwent a 6-week follow-up including an MRI with liver-specific contrast
agent of the liver to assess complete ablation, i.e., technical success of the ablation procedure
(Fig. 5). Ablations were considered complete when no areas of enhancement were seen in
the tumor or at the periphery. Images were analyzed by two experienced radiologists in
consensus reading.
Statistical analysis
The statistical software packages JMP (SAS Institute, Cary, NC, USA) and R (R Core Team,
2015) were used to perform the statistical analysis. Data were expressed as mean± standard
deviation. Outcomes were compared using Welch’s t -test for unequal variances with the
exception of electrode deviation, which was compared using the t -test for clustered data.
T -test statistics are reported with degrees of freedom in parentheses, the t statistic and
the significance level. A p-value of p≤ 0.05 was considered the cut-off point of statistical
significance.
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Table 2 Base patient and lesion aspects. Lesion conspicuity denotes the difference in attenuation be-
tween tumor and liver parenchyma in Hounsfield units (HUliver −HUlesion). Data are presented as means
and standard deviations.
Conventional or stereotactic CIRE (n= 10) SIRE (n= 10)
Sex (male) 9 (90 %) 9 (90 %)
Age—years 63.2± 8.6 69.0± 11.9
BMI—kg/m2 28.4± 4.1 29.0± 3.1
Skin to tumor depth—mm 79.8± 26.9 67.7± 25.2
Tumor long axis—mm 25.4± 8.1 25.0± 9.0
Tumor conspicuity native—HU 10.6± 7.8 12.8± 5.6
Tumor conspicuity enhanced—HU 35.6± 14.2 29.1± 7.6
Table 3 Time required for sterile patient preparation; placement of IRE electrodes and total intervention.Data are presented as means and stan-
dard deviations.
Conventional or stereotactic CIRE (n= 10) SIRE (n= 10) t -test
Sterile patient preparation duration—min 17.1± 2.8 16.1± 3.8 t (16.4)= 0.67, p= 0.514
Electrode placement duration—min 87.0± 29.9 26.8± 7.7 t (10.2)= 6.2, p< 0.001
Placement time per electrode—min 18.0± 4.2 5.9± 2.0 t (13.0)= 8.1, p< 0.001
Procedure time until start of the ablation—min 104.1± 28.2 55.2± 9.3 t (10.9)= 5.2, p< 0.001
RESULTS
Tumor characteristics
Baseline patient characteristics and lesion aspects are summarized in Table 2.
Procedural accuracy
The average deviation of the IRE electrodes with respect to the reference electrode was 3.3
mm ± 1.2 (range 0.8 mm–6.2 mm) for CIRE and 2.2 mm ± 0.9 (range 0.6 mm–4.0 mm)
for SIRE with the difference being statistically significant (p< 0.001). The corresponding
deviation expressed in degrees of arc was 9.3 ± 3.3 vs. 6.4 ± 2.6 (CIRE vs. SIRE).
Procedural duration
The average time required to complete sterile patient preparation, the electrode placement
time and the procedure time are reported in Table 3. In contrast to CIRE, SIRE requires
definition of the trajectories in the navigation system which required 12.3 min ± 4.0.
Radiation dose
The DLP of the entire intervention, the CT fluoroscopy and the verification scans were
significantly lower in SIRE compared to CIRE (Table 4).
Ablation success
In the follow-up after six weeks, complete ablation without residual tumor was seen in
100% (10 of 10) of robot-assisted ablation cases and in 100% (10 of 10) of manual ablation
cases.
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Table 4 Dose length product (DLP) of the entire intervention, CT fluoroscopy and all verification
scans.Data are presented as means and standard deviations.
Conventional or stereotactic CIRE (N = 10) SIRE (N = 10) t -test
Total DLP—mGy*cm 4886± 1775 3510± 887 t (13.2)=2.2, p= 0.047
Verification DLP—mGy*cm 1351± 479 725± 326 t (15.8)= 3.4, p= 0.004
Fluoroscopy DLP—mGy*cm 1705± 1583 136± 206 t (9.3)= 3.1, p= 0.012
Complications
There were no complications in navigation-assisted and manual ablation.
DISCUSSION
The aim of the present study was to evaluate stereotactic percutaneous IRE of malignant
liver tumors for the first time as a promising alternative to conventional percutaneous IRE
using CT fluoroscopy.
Both patient groups were comparable with regards to baseline patient and tumor
characteristics (Table 2). The difference of 12 mm in skin to tumor depth between both
groups was neither clinically nor statistically significant.
IRE relies on increasing the permeability of the cell membrane based on nanopores
induced by a strong electromagnetic field (Davalos, Mir & Rubinsky, 2005). If the electrical
field is powerful enough, the cell membrane is sufficiently damaged so that its integrity is
permanently altered, allowing the induction of apoptosis in the cell (Yarmush et al., 2014;
Jiang, Davalos & Bischof, 2015). Although new bipolar IRE electrodes are being developed
only monopolar electrodes are currently commercially available. These monopolar
electrodes must be placed parallel in order to generate a sufficiently strong electromagnetic
field within the entire tumor or ablation zone (Martin, 2013; Scheffer et al., 2015). The
consequent complexity of probe placement results in significantly longer intervention
times compared to thermal interventional methods. Thus, average intervention times
of 86 min have been reported for RFA of liver tumors supported by CT fluoroscopy
(Basdanis et al., 2004). On the other hand, intervention took an average of 170 min
for percutaneous CIRE (Ball, Thomson & Kavnoudias, 2010), primary due to the time-
consuming manual placement of the individual probes using CT fluoroscopy.
Deviations detected in the course of control scans and resulting repositioning of
individual probes represent a significant component of the distinctly longer intervention
times for IRE when compared to thermal ablation. In this context, the evaluation of
the benefit of stereotactic navigation technology for interventional radiology during IRE
procedures was the primary aim of this study. It was demonstrated that 3D treatment
planning on the navigation equipment resulted in an average planning time of 12.3 min.
However, in the end, electrode placement in the course of SIRE was distinctly faster with
5.9 min per electrode, compared to 18.0 min during CIRE. This likewise resulted in a
significant decrease in the total intervention time until ablation (104 min vs. 55 min;
p< 0.001).
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In the course of a prospective study of 70 patients, Mbalisike et al. (2014) determined
that robot-supported percutaneous microwave ablation provides very high precision.
According to their measurements there was a minor average deviation of the active center
of the microwave probe (1.9 mm) compared to the center of the tumor. Our own studies
using robot-assistedMWAof a total of 64 liver tumors found a comparablyminor deviation
of 1.3 mm (Beyer et al., 2015).
The distance of the electrodes from the tumor center is not a suitable measure for
determining the accuracy of the placement of the IRE electrodes, since they have to be
inserted in the periphery of the tumor as well as in the tumor center. Unlike thermal
ablation procedures, exactly parallel insertion of the IRE probes into the liver tissue is
decisive for therapeutic success. Therefore, in the course of our study, parallelism of the
inserted electrodes was evaluated as such rather than their relation to the tumor center. As
a result, for SIRE our study indicated an average deviation of 2.2 mm compared to 3.3 mm
for insertion of electrodes using CT fluoroscopy.
Systematic errors, i.e., deviation of all probes in the same direction, cannot be ruled out
with certainty by determining parallelism. Therefore, we view the short-term follow-up
(after 6 weeks) as the best measure of the success of ablation. In all 20 cases, technically
successful complete ablation was accomplished by both CIRE and SIRE.
In our study of percutaneous microwave ablation of malignant liver tumors, we showed
that robot support significantly reduced radiation exposure (Beyer et al., 2015). This applies
to SIRE all the more as not only one, but several probes have to be inserted. Particularly
great differences are seen in the DLP resulting from the use of CT fluoroscopy as well as in
the total radiation exposure of the patient during the course of intervention (Table 4).
During SIRE, the time-consuming manual placement of the ablation electrodes is
omitted. Instead, by using an aiming device in the specified insertion position, supported
by 3D planning and patient co-registration, the ablation electrodes could be inserted in
situ as one step.
In near future SIRE is probably not only a suitable method just for IRE of hepatic
malignancies, but also for treatment of deep-seated tumors in other anatomical regions.
For example one study has reported substantially prolonged survival for IRE as part of
multimodal treatment of locally advanced pancreatic cancer (Martin et al., 2015). The
placement of IRE electrodes in the pancreas is highly challenging because of the anatomical
characteristics, especially the long access path and immediate proximity to large vessels
which are respected by the IRE procedure. Therefore, we think that SIRE might be of high
value for treatment of pancreatic cancer, especially because of the high accuracy and fast
electrode placement, supported by strong 3D planning tools. Further studies should be
conducted to evaluate the benefits of SIRE for different anatomical regions.
This study has some limitations. The single-center setup and the low number of
procedures limits generalization of our results. In particular, reported results for the CIRE
are very operator dependent and may vary accordingly in different centers.
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Conclusion
In summary, SIRE may be associated with a marked reduction of procedure length and
high accuracy compared to CIRE. Stereotactic navigation has the potential to reduce
radiation dose for the patient without increasing the risk of complications or impaired
technical success compared to CIRE. Due to the high accuracy and focal nonthermal
ablation mechanism, SIRE might have the potential to be translated into the treatment of
deep-seated tumors in other anatomical regions, e.g., pancreatic cancer, in a near future.
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